E 10-K FILINGS Pharma Corp Consolidated Balance Sheets (USD $ In Millions, except Share data, unless otherwise specified Dec. 31, 2015 Dec. 31, 2014 (unaudited) [audited ASSETS Cash and cash equivalents $10 489 $3,287 Short-term investments 22,219 23.170 3 Accounts receivable, less allowance for doubtful accounts, 2045-$374; 2014-$226 12,478 13,158 10 Inventories 5,953 6,510 13 Takes and other current assets 9,196 9,480 12 Assets of discontinued operations and other assets held for sale 70 5,217 13 Total current assets 1,415 50.917 14 Long-term investments 14,249 9.914 35 property, plant and equipment, less accumulated depreciation 14,361 15.921 16 Goodwill 44,572 44,669 17 Identifiable intangible assets, less accumulated amortization 46,113 51,284 18 Tees and other noncurrent assets 5.088 5.697 3s Total assets 185,798 188,002 20 21 LIABILITIES AND EQUITIES zz short-term borrowings, including current portion of long-term debt: 2015-$2,449; 2014 6,524 -$6 4,116 23 Accounts payable 4,164 3.57 24 Dividends payable 1.834 1. 896 25 Income taxes payable 910 909 26 Accrued compensation and related items 2,146 2,220 27 Other current liabilities 13,041 15,066 28 Liabilities of discontinued operations 1. 124 23 Total current liabilities 28,719 28,90 30 Long-term debt 30,936 34.826 l Pension benefit obligations 7.930 6,458 82 Postretirement benefit obligations 3,393 3.244 33 Noncurrent deferred tax liabilities 21,593 18.86 34 Other taxes payable 6,610 6.886 35 Other noncurrent liabilities 4,939 6,100 316 Total liabilities 104,120 105 381 37 Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2015- 39 45 907: 2014-1,112 Common stock, $0.08 par value: 12,000 shares authorized; issued: 2015-8,956: 2014- 448 445 8.902 40 Additional paid-in capital 72,608 71, 423 41 Employee benefit trusts -1 42 Treasury stock, shares at cost: 2015-1,680; 2014-1,327 40,121 31, 801 3 Retained earnings 54.240 46.210 14 Accumulated other comprehensive loss -5,953 -4.129 45 Total shareholders' equity 81,260 82 190 46 Equity attributable to noncontrolling interests 418 431 7 Total equity 81,678 82 621 49 Total liabilities and equity 185,798 188,002